Imricor Medical Systems, Inc. (ASX:IMR)
1.740
0.00 (0.00%)
Jun 5, 2026, 4:10 PM AEST
Imricor Medical Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.5 | 15.71 | 0.83 | 5.69 | 18.52 |
Short-Term Investments | 21.28 | - | - | - | - |
Cash & Short-Term Investments | 40.78 | 15.71 | 0.83 | 5.69 | 18.52 |
Cash Growth | 159.62% | 1789.04% | -85.38% | -69.28% | -26.35% |
Receivables | 0.24 | 0.35 | 0.39 | 0.13 | 0.09 |
Inventory | 1.1 | 1.5 | 1.68 | 2.28 | 2.58 |
Prepaid Expenses | 0.8 | 0.79 | 1.03 | 1.59 | 1.51 |
Total Current Assets | 42.92 | 18.35 | 3.94 | 9.68 | 22.7 |
Property, Plant & Equipment | 2.14 | 2.6 | 3.17 | 3.56 | 3.6 |
Other Long-Term Assets | 0.7 | 0.68 | 1.2 | 0.46 | 0.57 |
Total Assets | 45.76 | 21.62 | 8.31 | 13.7 | 26.86 |
Accounts Payable | 0.5 | 0.33 | 2.1 | 0.26 | 0.69 |
Accrued Expenses | 1.62 | 1.49 | 0.79 | 0.92 | 1.35 |
Short-Term Debt | - | - | 0.36 | - | - |
Current Portion of Long-Term Debt | 11.75 | - | - | - | - |
Current Portion of Leases | 0.32 | 0.47 | 0.73 | 0.87 | 0.52 |
Current Unearned Revenue | 0.03 | 0.06 | 0.58 | 0.02 | 0.18 |
Other Current Liabilities | 3.16 | - | - | - | - |
Total Current Liabilities | 17.37 | 2.36 | 4.57 | 2.07 | 2.74 |
Long-Term Debt | 13.27 | 19.87 | 8.49 | 2.18 | - |
Long-Term Leases | 0.63 | 0.88 | 1.14 | 1.4 | 1.22 |
Long-Term Unearned Revenue | 1.09 | 1.1 | 0.79 | 0.49 | 0.51 |
Other Long-Term Liabilities | 1.87 | 4.8 | 2.08 | 0.04 | - |
Total Liabilities | 34.23 | 29 | 17.06 | 6.19 | 4.46 |
Common Stock | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 |
Additional Paid-In Capital | 179.09 | 134.88 | 103.82 | 97.46 | 94.99 |
Retained Earnings | -167.6 | -142.28 | -112.59 | -89.96 | -72.6 |
Shareholders' Equity | 11.52 | -7.38 | -8.75 | 7.51 | 22.4 |
Total Liabilities & Equity | 45.76 | 21.62 | 8.31 | 13.7 | 26.86 |
Total Debt | 25.97 | 21.21 | 10.71 | 4.45 | 1.74 |
Net Cash (Debt) | 14.81 | -5.51 | -9.88 | 1.24 | 16.78 |
Net Cash Growth | - | - | - | -92.60% | -25.90% |
Net Cash Per Share | 0.05 | -0.02 | -0.06 | 0.01 | 0.13 |
Filing Date Shares Outstanding | 320.95 | 270.18 | 168.92 | 151.35 | 143.23 |
Total Common Shares Outstanding | 320.95 | 270.18 | 168.92 | 151.35 | 143.23 |
Working Capital | 25.55 | 15.99 | -0.63 | 7.61 | 19.96 |
Book Value Per Share | 0.04 | -0.03 | -0.05 | 0.05 | 0.16 |
Tangible Book Value | 11.52 | -7.38 | -8.75 | 7.51 | 22.4 |
Tangible Book Value Per Share | 0.04 | -0.03 | -0.05 | 0.05 | 0.16 |
Machinery | 4.4 | 4.11 | 3.84 | 3.47 | 3.28 |
Leasehold Improvements | 1.64 | 1.64 | 1.64 | 1.64 | 1.6 |